Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer

Published:2019-09 Issue: Volume:46 Page:100644
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Leonetti Alessandro,Wever Birgit,Mazzaschi Giulia,Assaraf Yehuda G.,Rolfo Christian,Quaini Federico,Tiseo Marcello,Giovannetti Elisa

Funder

AIRC

Fondazione CARIPLO-Regione Lombardia

KWF

Fondazione Pisana per la Scienza

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference128 articles.

1. Role of natural killer cells in lung cancer;Aktaş;J. Cancer Res. Clin. Oncol.,2018

2. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer;Al-Shibli;Clin. Cancer Res.,2008

3. T-cell regulation by CD28 and CTLA-4;Alegre;Nat. Rev. Immunol.,2001

4. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy;Apetoh;Nat. Med.,2007

5. Molecular basis of antifolate resistance;Assaraf;Cancer Metastasis Rev.,2007

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy;Cellular Oncology;2024-08-19

2. The clinical significance of endoplasmic reticulum stress related genes in non-small cell lung cancer and analysis of single nucleotide polymorphism for CAV1;Frontiers in Molecular Biosciences;2024-08-06

3. Nomogram for Predicting Efficacy and Prognosis After Chemotherapy for Advanced NSCLC;The Clinical Respiratory Journal;2024-08

4. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients;International Immunopharmacology;2024-08

5. Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies;Cancer and Metastasis Reviews;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3